BIMI International Medical Inc. (BIMI)
NASDAQ: BIMI · IEX Real-Time Price · USD
1.150
+0.050 (4.54%)
At close: May 31, 2024, 4:00 PM
1.160
+0.010 (0.88%)
After-hours: May 31, 2024, 7:42 PM EDT
BIMI Market Cap
BIMI has a market cap or net worth of $13.33 million as of May 31, 2024. Its market cap has increased by 196.15% in one year.
Market Cap
13.33M
Enterprise Value
16.80M
1-Year Change
196.15%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since April 12, 2007, BIMI's market cap has decreased from $23.60M to $13.33M, a decrease of -43.53%. That is a compound annual growth rate of -3.28%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 13.30M | 4.72% |
May 30, 2024 | 12.70M | 1.60% |
May 29, 2024 | 12.50M | -0.79% |
May 28, 2024 | 12.60M | 1.61% |
May 24, 2024 | 12.40M | -5.34% |
May 23, 2024 | 13.10M | -5.76% |
May 22, 2024 | 13.90M | -1.42% |
May 21, 2024 | 14.10M | -10.76% |
May 20, 2024 | 15.80M | 8.22% |
May 17, 2024 | 14.60M | 9.77% |
May 16, 2024 | 13.30M | 4.72% |
May 15, 2024 | 12.70M | -2.31% |
May 14, 2024 | 13.00M | 4.00% |
May 13, 2024 | 12.50M | 1.63% |
May 10, 2024 | 12.30M | -5.38% |
May 9, 2024 | 13.00M | - |
May 8, 2024 | 13.00M | 0.78% |
May 7, 2024 | 12.90M | -3.01% |
May 6, 2024 | 13.30M | 4.72% |
May 3, 2024 | 12.70M | 4.96% |
May 2, 2024 | 12.10M | -11.03% |
May 1, 2024 | 13.60M | -1.45% |
Apr 30, 2024 | 13.80M | 1.47% |
Apr 29, 2024 | 13.60M | -4.90% |
Apr 26, 2024 | 14.30M | 3.62% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Minerva Neurosciences | 16.29M |
Tonix Pharmaceuticals Holding | 16.24M |
Flora Growth | 15.89M |
Mainz Biomed B.V. | 15.80M |
Cardio Diagnostics Holdings | 15.59M |
Calidi Biotherapeutics | 15.28M |
Chemomab Therapeutics | 15.07M |
Traws Pharma | 14.73M |